+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
COVID-19 Vaccines Market by Vaccine Technology (Inactivated, mRNA, Protein Subunit), Dosage Regimen (Booster Dose, Single Dose, Two Dose), Application Route, Packaging Type, Distribution Channel, End User, Procurement Model - Global Forecast 2025-2030- Product Image
COVID-19 Vaccines Market by Vaccine Technology (Inactivated, mRNA, Protein Subunit), Dosage Regimen (Booster Dose, Single Dose, Two Dose), Application Route, Packaging Type, Distribution Channel, End User, Procurement Model - Global Forecast 2025-2030- Product Image
Sale

COVID-19 Vaccines Market by Vaccine Technology (Inactivated, mRNA, Protein Subunit), Dosage Regimen (Booster Dose, Single Dose, Two Dose), Application Route, Packaging Type, Distribution Channel, End User, Procurement Model - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 192 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6011574
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The COVID-19 Vaccines Market is evolving rapidly as public health strategies, breakthrough technologies, and global collaboration drive ongoing changes. Strategic agility and informed planning are essential for organizations navigating this complex healthcare segment as it remains fundamental to pandemic resilience and future preparedness.

Market Snapshot: COVID-19 Vaccines Market Growth

The COVID-19 Vaccines Market grew from USD 237.12 billion in 2024 to USD 263.10 billion in 2025. It is expected to continue growing at a CAGR of 10.65%, reaching USD 435.31 billion by 2030. Robust advancements in vaccine platform technologies and expanding public and private demand are key contributors to this market’s expansion. As the vaccine landscape adapts to changing public health scenarios and variant progression, stakeholders must closely monitor shifting regulatory, logistical, and trade conditions to sustain growth and meet population needs.

Scope & Segmentation

This report delivers comprehensive coverage of all key segments and regional trends shaping the COVID-19 Vaccines Market:

  • Vaccine Technologies: Inactivated platforms, mRNA vaccines, protein subunit formulations (adjuvanted and non-adjuvanted options).
  • Dosage Strategies: Booster regimens, single-dose options, two-dose immunization schedules.
  • Application Routes: Intramuscular and intranasal vaccine administration methods.
  • Packaging Types: Prefilled syringes, vials, and other practical distribution formats.
  • Distribution Channels: Clinics, hospitals, and pharmacies delivering frontline access to immunization programs.
  • End Users: Adolescents, adults, children—each with distinct immunization protocols and communication needs.
  • Procurement Models: Government procurement systems and private purchase frameworks influencing market flow.
  • Regional Coverage: Americas (including the United States, Canada, key states, and Latin American countries), Europe, Middle East & Africa (expansive list of major and emerging market economies), Asia-Pacific (China, India, Japan, Australia, and other leading and developing regional players).
  • Leading Companies: Pfizer Inc., Moderna, AstraZeneca, Johnson & Johnson, China National Pharmaceutical Group, Sinovac, Serum Institute of India, and Novavax—each highlighting unique technological and manufacturing competencies.

Key Takeaways for Decision-Makers

  • The COVID-19 Vaccines Market displays resilience through scientific innovation and broad alliances, with mRNA advances driving both adaptability and speed in immunogen design.
  • Agile regulatory practices, such as rolling reviews and conditional authorizations, shorten timelines for new and enhanced formulations while maintaining critical safety standards.
  • Cross-sector funding approaches blend public, private, and philanthropic capital, accelerating candidate evaluation and market entry for novel vaccine types and delivery methods.
  • Regional strategies differ: established health infrastructure supports rapid rollouts in some regions, while others prioritize local manufacturing hubs or digital systems to optimize vaccine access.
  • Public-private collaborations and advanced procurement practices facilitate streamlined distribution and help align inventory management with on-the-ground needs.
  • Technology platform diversification—combining inactivated, protein subunit, and mRNA—remains vital for addressing evolving epidemiological and logistical challenges worldwide.

Tariff Impact on Vaccine Supply Chains

Recent tariff adjustments have increased raw material costs and introduced complexity to cross-border vaccine supply chains. Manufacturers are refining sourcing strategies, expanding regional supplier networks, and pursuing harmonized compliance protocols to ease import bottlenecks. These efforts enhance supply chain resilience and mitigate delays, ensuring more reliable access to essential vaccines in strategic markets despite evolving trade landscapes.

Methodology & Data Sources

This analysis leverages robust data from peer-reviewed publications, regulatory filings, and government trade notices. Qualitative insights are integrated through targeted interviews with experts in manufacturing, regulation, and distribution. Digital surveillance tools track real-time approvals and clinical advances, while stringent quality controls ensure transparent and validated conclusions.

Why This Report Matters for Senior Decision-Makers

  • Equips executives with in-depth, actionable insights to inform strategic investments, partnership development, and supply chain optimization amid rapid market evolution.
  • Provides an integrated view of scientific, regulatory, and commercial dynamics, helping leaders align operational and procurement decisions with future public health demands.
  • Supports proactive risk management through clarity on regional, technological, and trade-related factors shaping vaccine access and market opportunities.

Conclusion

The COVID-19 Vaccines Market is defined by adaptability, scientific progress, and strategic collaboration. Informed, agile decision-making will be fundamental for organizations to drive sustainable value and secure long-term immunization outcomes in this evolving sector.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Expansion of bivalent and multivalent vaccine formulations targeting emerging SARS-CoV-2 variants to enhance immune coverage
5.2. Rising emphasis on intranasal and mucosal vaccine candidates to improve transmission blockage and patient compliance
5.3. Strategic partnerships between biotech startups and big pharma for accelerated vaccine manufacturing capacity scaling
5.4. Regulatory milestone of conditional approvals for next-generation COVID vaccines in key global markets
5.5. Growing investor interest in thermostable mRNA vaccine platforms to facilitate distribution in low-resource settings
5.6. Increased focus on pediatric and maternal vaccination programs amid changing immunity profiles and dosing guidelines
5.7. Development of pan-coronavirus vaccine research initiatives aimed at broad protection against future zoonotic outbreaks
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. COVID-19 Vaccines Market, by Vaccine Technology
8.1. Introduction
8.2. Inactivated
8.3. mRNA
8.4. Protein Subunit
8.4.1. Adjuvanted
8.4.2. Non Adjuvanted
9. COVID-19 Vaccines Market, by Dosage Regimen
9.1. Introduction
9.2. Booster Dose
9.3. Single Dose
9.4. Two Dose
10. COVID-19 Vaccines Market, by Application Route
10.1. Introduction
10.2. Intramuscular
10.3. Intranasal
11. COVID-19 Vaccines Market, by Packaging Type
11.1. Introduction
11.2. Prefilled Syringe
11.3. Vial
12. COVID-19 Vaccines Market, by Distribution Channel
12.1. Introduction
12.2. Clinic
12.3. Hospital
12.4. Pharmacy
13. COVID-19 Vaccines Market, by End User
13.1. Introduction
13.2. Adolescent
13.3. Adult
13.4. Child
14. COVID-19 Vaccines Market, by Procurement Model
14.1. Introduction
14.2. Government Procurement
14.3. Private Purchase
15. Americas COVID-19 Vaccines Market
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. Argentina
16. Europe, Middle East & Africa COVID-19 Vaccines Market
16.1. Introduction
16.2. United Kingdom
16.3. Germany
16.4. France
16.5. Russia
16.6. Italy
16.7. Spain
16.8. United Arab Emirates
16.9. Saudi Arabia
16.10. South Africa
16.11. Denmark
16.12. Netherlands
16.13. Qatar
16.14. Finland
16.15. Sweden
16.16. Nigeria
16.17. Egypt
16.18. Turkey
16.19. Israel
16.20. Norway
16.21. Poland
16.22. Switzerland
17. Asia-Pacific COVID-19 Vaccines Market
17.1. Introduction
17.2. China
17.3. India
17.4. Japan
17.5. Australia
17.6. South Korea
17.7. Indonesia
17.8. Thailand
17.9. Philippines
17.10. Malaysia
17.11. Singapore
17.12. Vietnam
17.13. Taiwan
18. Competitive Landscape
18.1. Market Share Analysis, 2024
18.2. FPNV Positioning Matrix, 2024
18.3. Competitive Analysis
18.3.1. Pfizer Inc.
18.3.2. Moderna, Inc.
18.3.3. AstraZeneca PLC
18.3.4. Johnson & Johnson Services Inc.
18.3.5. China National Pharmaceutical Group Co., Ltd.
18.3.6. Sinovac Biotech Ltd.
18.3.7. Serum Institute of India Pvt. Ltd.
18.3.8. Novavax, Inc.
19. ResearchAI
20. ResearchStatistics
21. ResearchContacts
22. ResearchArticles
23. Appendix
List of Figures
FIGURE 1. COVID-19 VACCINES MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL COVID-19 VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL COVID-19 VACCINES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL COVID-19 VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL COVID-19 VACCINES MARKET SIZE, BY VACCINE TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 6. GLOBAL COVID-19 VACCINES MARKET SIZE, BY VACCINE TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL COVID-19 VACCINES MARKET SIZE, BY DOSAGE REGIMEN, 2024 VS 2030 (%)
FIGURE 8. GLOBAL COVID-19 VACCINES MARKET SIZE, BY DOSAGE REGIMEN, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL COVID-19 VACCINES MARKET SIZE, BY APPLICATION ROUTE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL COVID-19 VACCINES MARKET SIZE, BY APPLICATION ROUTE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL COVID-19 VACCINES MARKET SIZE, BY PACKAGING TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL COVID-19 VACCINES MARKET SIZE, BY PACKAGING TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL COVID-19 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL COVID-19 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL COVID-19 VACCINES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL COVID-19 VACCINES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL COVID-19 VACCINES MARKET SIZE, BY PROCUREMENT MODEL, 2024 VS 2030 (%)
FIGURE 18. GLOBAL COVID-19 VACCINES MARKET SIZE, BY PROCUREMENT MODEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS COVID-19 VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS COVID-19 VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES COVID-19 VACCINES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES COVID-19 VACCINES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA COVID-19 VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA COVID-19 VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC COVID-19 VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC COVID-19 VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. COVID-19 VACCINES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. COVID-19 VACCINES MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 29. COVID-19 VACCINES MARKET: RESEARCHAI
FIGURE 30. COVID-19 VACCINES MARKET: RESEARCHSTATISTICS
FIGURE 31. COVID-19 VACCINES MARKET: RESEARCHCONTACTS
FIGURE 32. COVID-19 VACCINES MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. COVID-19 VACCINES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL COVID-19 VACCINES MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL COVID-19 VACCINES MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL COVID-19 VACCINES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL COVID-19 VACCINES MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL COVID-19 VACCINES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL COVID-19 VACCINES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL COVID-19 VACCINES MARKET SIZE, BY VACCINE TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL COVID-19 VACCINES MARKET SIZE, BY VACCINE TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL COVID-19 VACCINES MARKET SIZE, BY INACTIVATED, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL COVID-19 VACCINES MARKET SIZE, BY INACTIVATED, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL COVID-19 VACCINES MARKET SIZE, BY MRNA, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL COVID-19 VACCINES MARKET SIZE, BY MRNA, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL COVID-19 VACCINES MARKET SIZE, BY PROTEIN SUBUNIT, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL COVID-19 VACCINES MARKET SIZE, BY PROTEIN SUBUNIT, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL COVID-19 VACCINES MARKET SIZE, BY ADJUVANTED, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL COVID-19 VACCINES MARKET SIZE, BY ADJUVANTED, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL COVID-19 VACCINES MARKET SIZE, BY NON ADJUVANTED, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL COVID-19 VACCINES MARKET SIZE, BY NON ADJUVANTED, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL COVID-19 VACCINES MARKET SIZE, BY PROTEIN SUBUNIT, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL COVID-19 VACCINES MARKET SIZE, BY PROTEIN SUBUNIT, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL COVID-19 VACCINES MARKET SIZE, BY DOSAGE REGIMEN, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL COVID-19 VACCINES MARKET SIZE, BY DOSAGE REGIMEN, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL COVID-19 VACCINES MARKET SIZE, BY BOOSTER DOSE, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL COVID-19 VACCINES MARKET SIZE, BY BOOSTER DOSE, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL COVID-19 VACCINES MARKET SIZE, BY SINGLE DOSE, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL COVID-19 VACCINES MARKET SIZE, BY SINGLE DOSE, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL COVID-19 VACCINES MARKET SIZE, BY TWO DOSE, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL COVID-19 VACCINES MARKET SIZE, BY TWO DOSE, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL COVID-19 VACCINES MARKET SIZE, BY APPLICATION ROUTE, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL COVID-19 VACCINES MARKET SIZE, BY APPLICATION ROUTE, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL COVID-19 VACCINES MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL COVID-19 VACCINES MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL COVID-19 VACCINES MARKET SIZE, BY INTRANASAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL COVID-19 VACCINES MARKET SIZE, BY INTRANASAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL COVID-19 VACCINES MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL COVID-19 VACCINES MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL COVID-19 VACCINES MARKET SIZE, BY PREFILLED SYRINGE, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL COVID-19 VACCINES MARKET SIZE, BY PREFILLED SYRINGE, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL COVID-19 VACCINES MARKET SIZE, BY VIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL COVID-19 VACCINES MARKET SIZE, BY VIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL COVID-19 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL COVID-19 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL COVID-19 VACCINES MARKET SIZE, BY CLINIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL COVID-19 VACCINES MARKET SIZE, BY CLINIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL COVID-19 VACCINES MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL COVID-19 VACCINES MARKET SIZE, BY HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL COVID-19 VACCINES MARKET SIZE, BY PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL COVID-19 VACCINES MARKET SIZE, BY PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL COVID-19 VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL COVID-19 VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL COVID-19 VACCINES MARKET SIZE, BY ADOLESCENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL COVID-19 VACCINES MARKET SIZE, BY ADOLESCENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL COVID-19 VACCINES MARKET SIZE, BY ADULT, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL COVID-19 VACCINES MARKET SIZE, BY ADULT, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL COVID-19 VACCINES MARKET SIZE, BY CHILD, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL COVID-19 VACCINES MARKET SIZE, BY CHILD, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL COVID-19 VACCINES MARKET SIZE, BY PROCUREMENT MODEL, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL COVID-19 VACCINES MARKET SIZE, BY PROCUREMENT MODEL, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL COVID-19 VACCINES MARKET SIZE, BY GOVERNMENT PROCUREMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL COVID-19 VACCINES MARKET SIZE, BY GOVERNMENT PROCUREMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL COVID-19 VACCINES MARKET SIZE, BY PRIVATE PURCHASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL COVID-19 VACCINES MARKET SIZE, BY PRIVATE PURCHASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS COVID-19 VACCINES MARKET SIZE, BY VACCINE TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS COVID-19 VACCINES MARKET SIZE, BY VACCINE TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS COVID-19 VACCINES MARKET SIZE, BY PROTEIN SUBUNIT, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS COVID-19 VACCINES MARKET SIZE, BY PROTEIN SUBUNIT, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS COVID-19 VACCINES MARKET SIZE, BY DOSAGE REGIMEN, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS COVID-19 VACCINES MARKET SIZE, BY DOSAGE REGIMEN, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS COVID-19 VACCINES MARKET SIZE, BY APPLICATION ROUTE, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS COVID-19 VACCINES MARKET SIZE, BY APPLICATION ROUTE, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS COVID-19 VACCINES MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS COVID-19 VACCINES MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS COVID-19 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS COVID-19 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS COVID-19 VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS COVID-19 VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS COVID-19 VACCINES MARKET SIZE, BY PROCUREMENT MODEL, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS COVID-19 VACCINES MARKET SIZE, BY PROCUREMENT MODEL, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS COVID-19 VACCINES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS COVID-19 VACCINES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES COVID-19 VACCINES MARKET SIZE, BY VACCINE TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES COVID-19 VACCINES MARKET SIZE, BY VACCINE TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES COVID-19 VACCINES MARKET SIZE, BY PROTEIN SUBUNIT, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES COVID-19 VACCINES MARKET SIZE, BY PROTEIN SUBUNIT, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES COVID-19 VACCINES MARKET SIZE, BY DOSAGE REGIMEN, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES COVID-19 VACCINES MARKET SIZE, BY DOSAGE REGIMEN, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES COVID-19 VACCINES MARKET SIZE, BY APPLICATION ROUTE, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES COVID-19 VACCINES MARKET SIZE, BY APPLICATION ROUTE, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES COVID-19 VACCINES MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES COVID-19 VACCINES MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES COVID-19 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES COVID-19 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES COVID-19 VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES COVID-19 VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES COVID-19 VACCINES MARKET SIZE, BY PROCUREMENT MODEL, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES COVID-19 VACCINES MARKET SIZE, BY PROCUREMENT MODEL, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES COVID-19 VACCINES MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES COVID-19 VACCINES MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 101. CANADA COVID-19 VACCINES MARKET SIZE, BY VACCINE TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 102. CANADA COVID-19 VACCINES MARKET SIZE, BY VACCINE TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 103. CANADA COVID-19 VACCINES MARKET SIZE, BY PROTEIN SUBUNIT, 2018-2024 (USD MILLION)
TABLE 104. CANADA COVID-19 VACCINES MARKET SIZE, BY PROTEIN SUBUNIT, 2025-2030 (USD MILLION)
TABLE 105. CANADA COVID-19 VACCINES MARKET SIZE, BY DOSAGE REGIMEN, 2018-2024 (USD MILLION)
TABLE 106. CANADA COVID-19 VACCINES MARKET SIZE, BY DOSAGE REGIMEN, 2025-2030 (USD MILLION)
TABLE 107. CANADA COVID-19 VACCINES MARKET SIZE, BY APPLICATION ROUTE, 2018-2024 (USD MILLION)
TABLE 108. CANADA COVID-19 VACCINES MARKET SIZE, BY APPLICATION ROUTE, 2025-2030 (USD MILLION)
TABLE 109. CANADA COVID-19 VACCINES MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 110. CANADA COVID-19 VACCINES MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 111. CANADA COVID-19 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 112. CANADA COVID-19 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 113. CANADA COVID-19 VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 114. CANADA COVID-19 VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 115. CANADA COVID-19 VACCINES MARKET SIZE, BY PROCUREMENT MODEL, 2018-2024 (USD MILLION)
TABLE 116. CANADA COVID-19 VACCINES MARKET SIZE, BY PROCUREMENT MODEL, 2025-2030 (USD MILLION)
TABLE 117. MEXICO COVID-19 VACCINES MARKET SIZE, BY VACCINE TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 118. MEXICO COVID-19 VACCINES MARKET SIZE, BY VACCINE TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 119. MEXICO COVID-19 VACCINES MARKET SIZE, BY PROTEIN SUBUNIT, 2018-2024 (USD MILLION)
TABLE 120. MEXICO COVID-19 VACCINES MARKET SIZE, BY PROTEIN SUBUNIT, 2025-2030 (USD MILLION)
TABLE 121. MEXICO COVID-19 VACCINES MARKET SIZE, BY DOSAGE REGIMEN, 2018-2024 (USD MILLION)
TABLE 122. MEXICO COVID-19 VACCINES MARKET SIZE, BY DOSAGE REGIMEN, 2025-2030 (USD MILLION)
TABLE 123. MEXICO COVID-19 VACCINES MARKET SIZE, BY APPLICATION ROUTE, 2018-2024 (USD MILLION)
TABLE 124. MEXICO COVID-19 VACCINES MARKET SIZE, BY APPLICATION ROUTE, 2025-2030 (USD MILLION)
TABLE 125. MEXICO COVID-19 VACCINES MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 126. MEXICO COVID-19 VACCINES MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 127. MEXICO COVID-19 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 128. MEXICO COVID-19 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 129. MEXICO COVID-19 VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 130. MEXICO COVID-19 VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 131. MEXICO COVID-19 VACCINES MARKET SIZE, BY PROCUREMENT MODEL, 2018-2024 (USD MILLION)
TABLE 132. MEXICO COVID-19 VACCINES MARKET SIZE, BY PROCUREMENT MODEL, 2025-2030 (USD MILLION)
TABLE 133. BRAZIL COVID-19 VACCINES MARKET SIZE, BY VACCINE TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 134. BRAZIL COVID-19 VACCINES MARKET SIZE, BY VACCINE TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 135. BRAZIL COVID-19 VACCINES MARKET SIZE, BY PROTEIN SUBUNIT, 2018-2024 (USD MILLION)
TABLE 136. BRAZIL COVID-19 VACCINES MARKET SIZE, BY PROTEIN SUBUNIT, 2025-2030 (USD MILLION)
TABLE 137. BRAZIL COVID-19 VACCINES MARKET SIZE, BY DOSAGE REGIMEN, 2018-2024 (USD MILLION)
TABLE 138. BRAZIL COVID-19 VACCINES MARKET SIZE, BY DOSAGE REGIMEN, 2025-2030 (USD MILLION)
TABLE 139. BRAZIL COVID-19 VACCINES MARKET SIZE, BY APPLICATION ROUTE, 2018-2024 (USD MILLION)
TABLE 140. BRAZIL COVID-19 VACCINES MARKET SIZE, BY APPLICATION ROUTE, 2025-2030 (USD MILLION)
TABLE 141. BRAZIL COVID-19 VACCINES MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 142. BRAZIL COVID-19 VACCINES MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 143. BRAZIL COVID-19 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 144. BRAZIL COVID-19 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 145. BRAZIL COVID-19 VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 146. BRAZIL COVID-19 VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 147. BRAZIL COVID-19 VACCINES MARKET SIZE, BY PROCUREMENT MODEL, 2018-2024 (USD MILLION)
TABLE 148. BRAZIL COVID-19 VACCINES MARKET SIZE, BY PROCUREMENT MODEL, 2025-2030 (USD MILLION)
TABLE 149. ARGENTINA COVID-19 VACCINES MARKET SIZE, BY VACCINE TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 150. ARGENTINA COVID-19 VACCINES MARKET SIZE, BY VACCINE TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 151. ARGENTINA COVID-19 VACCINES MARKET SIZE, BY PROTEIN SUBUNIT, 2018-2024 (USD MILLION)
TABLE 152. ARGENTINA COVID-19 VACCINES MARKET SIZE, BY PROTEIN SUBUNIT, 2025-2030 (USD MILLION)
TABLE 153. ARGENTINA COVID-19 VACCINES MARKET SIZE, BY DOSAGE REGIMEN, 2018-2024 (USD MILLION)
TABLE 154. ARGENTINA COVID-19 VACCINES MARKET SIZE, BY DOSAGE REGIMEN, 2025-2030 (USD MILLION)
TABLE 155. ARGENTINA COVID-19 VACCINES MARKET SIZE, BY APPLICATION ROUTE, 2018-2024 (USD MILLION)
TABLE 156. ARGENTINA COVID-19 VACCINES MARKET SIZE, BY APPLICATION ROUTE, 2025-2030 (USD MILLION)
TABLE 157. ARGENTINA COVID-19 VACCINES MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 158. ARGENTINA COVID-19 VACCINES MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 159. ARGENTINA COVID-19 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 160. ARGENTINA COVID-19 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 161. ARGENTINA COVID-19 VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 162. ARGENTINA COVID-19 VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 163. ARGENTINA COVID-19 VACCINES MARKET SIZE, BY PROCUREMENT MODEL, 2018-2024 (USD MILLION)
TABLE 164. ARGENTINA COVID-19 VACCINES MARKET SIZE, BY PROCUREMENT MODEL, 2025-2030 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA COVID-19 VACCINES MARKET SIZE, BY VACCINE TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA COVID-19 VACCINES MARKET SIZE, BY VACCINE TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA COVID-19 VACCINES MARKET SIZE, BY PROTEIN SUBUNIT, 2018-2024 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA COVID-19 VACCINES MARKET SIZE, BY PROTEIN SUBUNIT, 2025-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA COVID-19 VACCINES MARKET SIZE, BY DOSAGE REGIMEN, 2018-2024 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA COVID-19 VACCINES MARKET SIZE, BY DOSAGE REGIMEN, 2025-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA COVID-19 VACCINES MARKET SIZE, BY APPLICATION ROUTE, 2018-2024 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA COVID-19 VACCINES MARKET SIZE, BY APPLICATION ROUTE, 2025-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA COVID-19 VACCINES MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA COVID-19 VACCINES MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA COVID-19 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA COVID-19 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA COVID-19 VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA COVID-19 VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA COVID-19 VACCINES MARKET SIZE, BY PROCUREMENT MODEL, 2018-2024 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA COVID-19 VACCINES MARKET SIZE, BY PROCUREMENT MODEL, 2025-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA COVID-19 VACCINES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA COVID-19 VACCINES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 183. UNITED KINGDOM COVID-19 VACCINES MARKET SIZE, BY VACCINE TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 184. UNITED KINGDOM COVID-19 VACCINES MARKET SIZE, BY VACCINE TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM COVID-19 VACCINES MARKET SIZE, BY PROTEIN SUBUNIT, 2018-2024 (USD MILLION)
TABLE 186. UNITED KINGDOM COVID-19 VACCINES MARKET SIZE, BY PROTEIN SUBUNIT, 2025-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM COVID-19 VACCINES MARKET SIZE, BY DOSAGE REGIMEN, 2018-2024 (USD MILLION)
TABLE 188. UNITED KINGDOM COVID-19 VACCINES MARKET SIZE, BY DOSAGE REGIMEN, 2025-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM COVID-19 VACCINES MARKET SIZE, BY APPLICATION ROUTE, 2018-2024 (USD MILLION)
TABLE 190. UNITED KINGDOM COVID-19 VACCINES MARKET SIZE, BY APPLICATION ROUTE, 2025-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM COVID-19 VACCINES MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 192. UNITED KINGDOM COVID-19 VACCINES MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM COVID-19 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 194. UNITED KINGDOM COVID-19 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM COVID-19 VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 196. UNITED KINGDOM COVID-19 VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 197. UNITED KINGDOM COVID-19 VACCINES MARKET SIZE, BY PROCUREMENT MODEL, 2018-2024 (USD MILLION)
TABLE 198. UNITED KINGDOM COVID-19 VACCINES MARKET SIZE, BY PROCUREMENT MODEL, 2025-2030 (USD MILLION)
TABLE 199. GERMANY COVID-19 VACCINES MARKET SIZE, BY VACCINE TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 200. GERMANY COVID-19 VACCINES MARKET SIZE, BY VACCINE TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 201. GERMANY COVID-19 VACCINES MARKET SIZE, BY PROTEIN SUBUNIT, 2018-2024 (USD MILLION)
TABLE 202. GERMANY COVID-19 VACCINES MARKET SIZE, BY PROTEIN SUBUNIT, 2025-2030 (USD MILLION)
TABLE 203. GERMANY COVID-19 VACCINES MARKET SIZE, BY DOSAGE REGIMEN, 2018-2024 (USD MILLION)
TABLE 204. GERMANY COVID-19 VACCINES MARKET SIZE, BY DOSAGE REGIMEN, 2025-2030 (USD MILLION)
TABLE 205. GERMANY COVID-19 VACCINES MARKET SIZE, BY APPLICATION ROUTE, 2018-2024 (USD MILLION)
TABLE 206. GERMANY COVID-19 VACCINES MARKET SIZE, BY APPLICATION ROUTE, 2025-2030 (USD MILLION)
TABLE 207. GERMANY COVID-19 VACCINES MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 208. GERMANY COVID-19 VACCINES MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 209. GERMANY COVID-19 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 210. GERMANY COVID-19 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 211. GERMANY COVID-19 VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 212. GERMANY COVID-19 VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 213. GERMANY COVID-19 VACCINES MARKET SIZE, BY PROCUREMENT MODEL, 2018-2024 (USD MILLION)
TABLE 214. GERMANY COVID-19 VACCINES MARKET SIZE, BY PROCUREMENT MODEL, 2025-2030 (USD MILLION)
TABLE 215. FRANCE COVID-19 VACCINES MARKET SIZE, BY VACCINE TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 216. FRANCE COVID-19 VACCINES MARKET SIZE, BY VACCINE TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 217. FRANCE COVID-19 VACCINES MARKET SIZE, BY PROTEIN SUBUNIT, 2018-2024 (USD MILLION)
TABLE 218. FRANCE COVID-19 VACCINES MARKET SIZE, BY PROTEIN SUBUNIT, 2025-2030 (USD MILLION)
TABLE 219. FRANCE COVID-19 VACCINES MARKET SIZE, BY DOSAGE REGIMEN, 2018-2024 (USD MILLION)
TABLE 220. FRANCE COVID-19 VACCINES MARKET SIZE, BY DOSAGE REGIMEN, 2025-2030 (USD MILLION)
TABLE 221. FRANCE COVID-19 VACCINES MARKET SIZE, BY APPLICATION ROUTE, 2018-2024 (USD MILLION)
TABLE 222. FRANCE COVID-19 VACCINES MARKET SIZE, BY APPLICATION ROUTE, 2025-2030 (USD MILLION)
TABLE 223. FRANCE COVID-19 VACCINES MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 224. FRANCE COVID-19 VACCINES MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 225. FRANCE COVID-19 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 226. FRANCE COVID-19 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 227. FRANCE COVID-19 VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 228. FRANCE COVID-19 VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 229. FRANCE COVID-19 VACCINES MARKET SIZE, BY PROCUREMENT MODEL, 2018-2024 (USD MILLION)
TABLE 230. FRANCE COVID-19 VACCINES MARKET SIZE, BY PROCUREMENT MODEL, 2025-2030 (USD MILLION)
TABLE 231. RUSSIA COVID-19 VACCINES MARKET SIZE, BY VACCINE TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 232. RUSSIA COVID-19 VACCINES MARKET SIZE, BY VACCINE TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 233. RUSSIA COVID-19 VACCINES MARKET SIZE, BY PROTEIN SUBUNIT, 2018-2024 (USD MILLION)
TABLE 234. RUSSIA COVID-19 VACCINES MARKET SIZE, BY PROTEIN SUBUNIT, 2025-2030 (USD MILLION)
TABLE 235. RUSSIA COVID-19 VACCINES MARKET SIZE, BY DOSAGE REGIMEN, 2018-2024 (USD MILLION)
TABLE 236. RUSSIA COVID-19 VACCINES MARKET SIZE, BY DOSAGE REGIMEN, 2025-2030 (USD MILLION)
TABLE 237. RUSSIA COVID-19 VACCINES MARKET SIZE, BY APPLICATION ROUTE, 2018-2024 (USD MILLION)
TABLE 238. RUSSIA COVID-19 VACCINES MARKET SIZE, BY APPLICATION ROUTE, 2025-2030 (USD MILLION)
TABLE 239. RUSSIA COVID-19 VACCINES MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 240. RUSSIA COVID-19 VACCINES MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 241. RUSSIA COVID-19 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 242. RUSSIA COVID-19 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 243. RUSSIA COVID-19 VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 244. RUSSIA COVID-19 VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 245. RUSSIA COVID-19 VACCINES MARKET SIZE, BY PROCUREMENT MODEL, 2018-2024 (USD MILLION)
TABLE 246. RUSSIA COVID-19 VACCINES MARKET SIZE, BY PROCUREMENT MODEL, 2025-2030 (USD MILLION)
TABLE 247. ITALY COVID-19 VACCINES MARKET SIZE, BY VACCINE TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 248. ITALY COVID-19 VACCINES MARKET SIZE, BY VACCINE TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 249. ITALY COVID-19 VACCINES MARKET SIZE, BY PROTEIN SUBUNIT, 2018-2024 (USD MILLION)
TABLE 250. ITALY COVID-19 VACCINES MARKET SIZE, BY PROTEIN SUBUNIT, 2025-2030 (USD MILLION)
TABLE 251. ITALY COVID-19 VACCINES MARKET SIZE, BY DOSAGE REGIMEN, 2018-2024 (USD MILLION)
TABLE 252. ITALY COVID-19 VACCINES MARKET SIZE, BY DOSAGE REGIMEN, 2025-2030 (USD MILLION)
TABLE 253. ITALY COVID-19 VACCINES MARKET SIZE, BY APPLICATION ROUTE, 2018-2024 (USD MILLION)
TABLE 254. ITALY COVID-19 VACCINES MARKET SIZE, BY APPLICATION ROUTE, 2025-2030 (USD MILLION)
TABLE 255. ITALY COVID-19 VACCINES MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 256. ITALY COVID-19 VACCINES MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 257. ITALY COVID-19 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 258. ITALY COVID-19 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 259. ITALY COVID-19 VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 260. ITALY COVID-19 VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 261. ITALY COVID-19 VACCINES MARKET SIZE, BY PROCUREMENT MODEL, 2018-2024 (USD MILLION)
TABLE 262. ITALY COVID-19 VACCINES MARKET SIZE, BY PROCUREMENT MODEL, 2025-2030 (USD MILLION)
TABLE 263. SPAIN COVID-19 VACCINES MARKET SIZE, BY VACCINE TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 264. SPAIN COVID-19 VACCINES MARKET SIZE, BY VACCINE TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 265. SPAIN COVID-19 VACCINES MARKET SIZE, BY PROTEIN SUBUNIT, 2018-2024 (USD MILLION)
TABLE 266. SPAIN COVID-19 VACCINES MARKET SIZE, BY PROTEIN SUBUNIT, 2025-2030 (USD MILLION)
TABLE 267. SPAIN COVID-19 VACCINES MARKET SIZE, BY DOSAGE REGIMEN, 2018-2024 (USD MILLION)
TABLE 268. SPAIN COVID-19 VACCINES MARKET SIZE, BY DOSAGE REGIMEN, 2025-2030 (USD MILLION)
TABLE 269. SPAIN COVID-19 VACCINES MARKET SIZE, BY APPLICATION ROUTE, 2018-2024 (USD MILLION)
TABLE 270. SPAIN COVID-19 VACCINES MARKET SIZE, BY APPLICATION ROUTE, 2025-2030 (USD MILLION)
TABLE 271. SPAIN COVID-19 VACCINES MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 272. SPAIN COVID-19 VACCINES MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 273. SPAIN COVID-19 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 274. SPAIN COVID-19 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 275. SPAIN COVID-19 VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 276. SPAIN COVID-19 VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 277. SPAIN COVID-19 VACCINES MARKET SIZE, BY PROCUREMENT MODEL, 2018-2024 (USD MILLION)
TABLE 278. SPAIN COVID-19 VACCINES MARKET SIZE, BY PROCUREMENT MODEL, 2025-2030 (USD MILLION)
TABLE 279. UNITED ARAB EMIRATES COVID-19 VACCINES MARKET SIZE, BY VACCINE TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 280. UNITED ARAB EMIRATES COVID-19 VACCINES MARKET SIZE, BY VACCINE TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 281. UNITED ARAB EMIRATES COVID-19 VACCINES MARKET SIZE, BY PROTEIN SUBUNIT, 2018-2024 (USD MILLION)
TABLE 282. UNITED ARAB EMIRATES COVID-19 VACCINES MARKET SIZE, BY PROTEIN SUBUNIT, 2025-2030 (USD MILLION)
TABLE 283. UNITED ARAB EMIRATES COVID-19 VACCINES MARKET SIZE, BY DOSAGE REGIMEN, 2018-2024 (USD MILLION)
TABLE 284. UNITED ARAB EMIRATES COVID-19 VACCINES MARKET SIZE, BY DOSAGE REGIMEN, 2025-2030 (USD MILLION)
TABLE 285. UNITED ARAB EMIRATES COVID-19 VACCINES MARKET SIZE, BY APPLICATION ROUTE, 2018-2024 (USD MILLION)
TABLE 286. UNITED ARAB EMIRATES COVID-19 VACCINES MARKET SIZE, BY APPLICATION ROUTE, 2025-2030 (USD MILLION)
TABLE 287. UNITED ARAB EMIRATES COVID-19 VACCINES MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 288. UNITED ARAB EMIRATES COVID-19 VACCINES MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 289. UNITED ARAB EMIRATES COVID-19 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 290. UNITED ARAB EMIRATES COVID-19 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 291. UNITED ARAB EMIRATES COVID-19 VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 292. UNITED ARAB EMIRATES COVID-19 VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 293. UNITED ARAB EMIRATES COVID-19 VACCINES MARKET SIZE, BY PROCUREMENT MODEL, 2018-2024 (USD MILLION)
TABLE 294. UNITED ARAB EMIRATES COVID-19 VACCINES MARKET SIZE, BY PROCUREMENT MODEL, 2025-2030 (USD MILLION)
TABLE 295. SAUDI ARABIA COVID-19 VACCINES MARKET SIZE, BY VACCINE TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 296. SAUDI ARABIA COVID-19 VACCINES MARKET SIZE, BY VACCINE TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 297. SAUDI ARABIA COVID-19 VACCINES MARKET SIZE, BY PROTEIN SUBUNIT, 2018-2024 (USD MILLION)
TABLE 298. SAUDI ARABIA COVID-19 VACCINES MARKET SIZE, BY PROTEIN SUBUNIT, 2025-2030 (USD MILLION)
TABLE 299. SAUDI ARABIA COVID-19 VACCINES MARKET SIZE, BY DOSAGE REGIMEN, 2018-2024 (USD MILLION)
TABLE 300. SAUDI ARABIA COVID-19 VACCINES MARKET SIZE, BY DOSAGE REGIMEN, 2025-2030 (USD MILLION)
TABLE 301. SAUDI ARABIA COVID-19 VACCINES MARKET SIZE, BY APPLICATION ROUTE, 2018-2024 (USD MILLION)
TABLE 302. SAUDI ARABIA COVID-19 VACCINES MARKET SIZE, BY APPLICATION ROUTE, 2025-2030 (USD MILLION)
TABLE 303. SAUDI ARABIA COVID-19 VACCINES MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 304. SAUDI ARABIA COVID-19 VACCINES MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 305. SAUDI ARABIA COVID-19 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 306. SAUDI ARABIA COVID-19 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 307. SAUDI ARABIA COVID-19 VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 308. SAUDI ARABIA COVID-19 VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 309. SAUDI ARABIA COVID-19 VACCINES MARKET SIZE, BY PROCUREMENT MODEL, 2018-2024 (USD MILLION)
TABLE 310. SAUDI ARABIA COVID-19 VACCINES MARKET SIZE, BY PROCUREMENT MODEL, 2025-2030 (USD MILLION)
TABLE 311. SOUTH AFRICA COVID-19 VACCINES MARKET SIZE, BY VACCINE TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 312. SOUTH AFRICA COVID-19 VACCINES MARKET SIZE, BY VACCINE TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 313. SOUTH AFRICA COVID-19 VACCINES MARKET SIZE, BY PROTEIN SUBUNIT, 2018-2024 (USD MILLION)
TABLE 314. SOUTH AFRICA COVID-19 VACCINES MARKET SIZE, BY PROTEIN SUBUNIT, 2025-2030 (USD MILLION)
TABLE 315. SOUTH AFRICA COVID-19 VACCINES MARKET SIZE, BY DOSAGE REGIMEN, 2018-2024 (USD MILLION)
TABLE 316. SOUTH AFRICA COVID-19 VACCINES MARKET SIZE, BY DOSAGE REGIMEN, 2025-2030 (USD MILLION)
TABLE 317. SOUTH AFRICA COVID-19 VACCINES MARKET SIZE, BY APPLICATION ROUTE, 2018-2024 (USD MILLION)
TABLE 318. SOUTH AFRICA COVID-19 VACCINES MARKET SIZE, BY APPLICATION ROUTE, 2025-2030 (USD MILLION)
TABLE 319. SOUTH AFRICA COVID-19 VACCINES MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 320. SOUTH AFRICA COVID-19 VACCINES MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 321. SOUTH AFRICA COVID-19 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 322. SOUTH AFRICA COVID-19 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 323. SOUTH AFRICA COVID-19 VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 324. SOUTH AFRICA COVID-19 VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 325. SOUTH AFRICA COVID-19 VACCINES MARKET SIZE, BY PROCUREMENT MODEL, 2018-2024 (USD MILLION)
TABLE 326. SOUTH AFRICA COVID-19 VACCINES MARKET SIZE, BY PROCUREMENT MODEL, 2025-2030 (USD MILLION)
TABLE 327. DENMARK COVID-19 VACCINES MARKET SIZE, BY VACCINE TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 328. DENMARK COVID-19 VACCINES MARKET SIZE, BY VACCINE TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 329. DENMARK COVID-19 VACCINES MARKET SIZE, BY PROTEIN SUBUNIT, 2018-2024 (USD MILLION)
TABLE 330. DENMARK COVID-19 VACCINES MARKET SIZE, BY PROTEIN SUBUNIT, 2025-2030 (USD MILLION)
TABLE 331. DENMARK COVID-19 VACCINES MARKET SIZE, BY DOSAGE REGIMEN, 2018-2024 (USD MILLION)
TABLE 332. DENMARK COVID-19 VACCINES MARKET SIZE, BY DOSAGE REGIMEN, 2025-2030 (USD MILLION)
TABLE 333. DENMARK COVID-19 VACCINES MARKET SIZE, BY APPLICATION ROUTE, 2018-2024 (USD MILLION)
TABLE 334. DENMARK COVID-19 VACCINES MARKET SIZE, BY APPLICATION ROUTE, 2025-2030 (USD MILLION)
TABLE 335. DENMARK COVID-19 VACCINES MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 336. DENMARK COVID-19 VACCINES MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 337. DENMARK COVID-19 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 338. DENMARK COVID-19 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 339. DENMARK COVID-19 VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 340. DENMARK COVID-

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this COVID-19 Vaccines market report include:
  • Pfizer Inc.
  • Moderna, Inc.
  • AstraZeneca PLC
  • Johnson & Johnson Services Inc.
  • China National Pharmaceutical Group Co., Ltd.
  • Sinovac Biotech Ltd.
  • Serum Institute of India Pvt. Ltd.
  • Novavax, Inc.

Table Information

Report AttributeDetails
No. of Pages192
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 263.1 Billion
Forecasted Market Value ( USD ) by 2030 $ 435.31 Billion
Compound Annual Growth Rate10.6%
Regions CoveredGlobal
No. of Companies Mentioned9

Related Topics

Related Reports

Adult Vaccines Market by Vaccine Type (Covid 19, Hepatitis, Herpes Zoster), Vaccine Technology (Conjugate, Dna, Inactivated), Route of Administration, Distribution Channel, Age Group - Global Forecast 2025-2030 - Product Image

Adult Vaccines Market by Vaccine Type (Covid 19, Hepatitis, Herpes Zoster), Vaccine Technology (Conjugate, Dna, Inactivated), Route of Administration, Distribution Channel, Age Group - Global Forecast 2025-2030

  • Report
  • 181 Pages
  • Global
From
Vaccines Market by Type (Inactivated Vaccines, Live-Attenuated Vaccines, Messenger RNA Vaccines), Product Type (BCG, COVID-19, DPTa), Vaccine Combination, Vaccine Classification, Route of Administration, Dosage, Age Group, End User - Global Forecast 2025-2030 - Product Image

Vaccines Market by Type (Inactivated Vaccines, Live-Attenuated Vaccines, Messenger RNA Vaccines), Product Type (BCG, COVID-19, DPTa), Vaccine Combination, Vaccine Classification, Route of Administration, Dosage, Age Group, End User - Global Forecast 2025-2030

  • Report
  • 186 Pages
  • Global
From
COVID-19 Vaccine Packaging And Delivery Devices Market Size, Share & Trends Analysis Report By Product (Syringes, Vials), By Region (North America, Europe, Asia Pacific, Latin America, MEA), And Segment Forecasts, 2025 - 2030 - Product Image

COVID-19 Vaccine Packaging And Delivery Devices Market Size, Share & Trends Analysis Report By Product (Syringes, Vials), By Region (North America, Europe, Asia Pacific, Latin America, MEA), And Segment Forecasts, 2025 - 2030

  • Report
  • 130 Pages
  • Global
From
Respiratory Disease Vaccine Market Size, Share & Trends Analysis Report by Type (Viral, Bacterial, Combination), Infection (COVID-19, Influenza), Age Group, Distribution Channel, and Region with Growth Forecasts, 2025-2030 - Product Image

Respiratory Disease Vaccine Market Size, Share & Trends Analysis Report by Type (Viral, Bacterial, Combination), Infection (COVID-19, Influenza), Age Group, Distribution Channel, and Region with Growth Forecasts, 2025-2030

  • Report
  • 100 Pages
  • Global
From
COVID-19 Vaccines - Global Strategic Business Report - Product Image

COVID-19 Vaccines - Global Strategic Business Report

  • Report
  • 762 Pages
  • Global
From

About the COVID 19 Vaccine Market

The COVID 19 Vaccine market is a rapidly growing sector of the Vaccines industry. It is driven by the urgent need to develop a safe and effective vaccine to protect against the novel coronavirus. Companies in the market are working to develop and manufacture vaccines that can be used to protect people from the virus. Vaccines are being developed using a variety of technologies, including mRNA, DNA, and viral vector-based approaches. The COVID 19 Vaccine market is highly competitive, with many companies vying for a share of the market. Companies are investing heavily in research and development to develop vaccines that are safe and effective. They are also investing in manufacturing and distribution capabilities to ensure that the vaccines can be quickly and efficiently delivered to those who need them. Some of the companies in the COVID 19 Vaccine market include Pfizer, Moderna, Johnson & Johnson, AstraZeneca, Novavax, and Sanofi. These companies are working to develop and manufacture vaccines that can be used to protect people from the virus. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.